"The Report Cystic
Fibrosis - Pipeline Review, H1 2016 provides information on pricing,
market analysis, shares, forecast, and company profiles for key
industry participants. - MarketResearchReports.biz"
Global
Markets Directs, Cystic
Fibrosis - Pipeline Review, H1 2016,
provides an overview of the Cystic Fibrosis pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Cystic Fibrosis, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Cystic Fibrosis and features dormant
and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Cystic Fibrosis
-
The report reviews pipeline therapeutics for Cystic Fibrosis by
companies and universities/research institutes based on information
derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Cystic Fibrosis therapeutics
and enlists all their major and minor projects
-
The report assesses Cystic Fibrosis therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Cystic Fibrosis
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Cystic Fibrosis
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Cystic Fibrosis pipeline depth and focus of Indication therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Follow us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
Table
of Contents 2
List
of Tables 8
List
of Figures 10
Introduction
11
Global
Markets Direct Report Coverage 11
Cystic
Fibrosis Overview 12
Therapeutics
Development 13
Pipeline
Products for Cystic Fibrosis - Overview 13
Pipeline
Products for Cystic Fibrosis - Comparative Analysis 14
Cystic
Fibrosis - Therapeutics under Development by Companies 15
Cystic
Fibrosis - Therapeutics under Investigation by
Universities/Institutes 21
Cystic
Fibrosis - Pipeline Products Glance 22
Late
Stage Products 22
Clinical
Stage Products 23
Early
Stage Products 24
Unknown
Stage Products 25
Cystic
Fibrosis - Products under Development by Companies 26
Cystic
Fibrosis - Products under Investigation by Universities/Institutes 34
Cystic
Fibrosis - Companies Involved in Therapeutics Development 35
Actelion
Ltd 35
Akari
Therapeutics, Plc 36
Alaxia
SAS 37
AlgiPharma
AS 38
AmpliPhi
Biosciences Corporation 39
Arcturus
Therapeutics, Inc 40
Aridis
Pharmaceuticals LLC 41
AstraZeneca
Plc 42
Bayer
AG 43
Boehringer
Ingelheim GmbH 44
Calista
Therapeutics, Inc. 45
Carolus
Therapeutics, Inc. 46
Celtaxsys,
Inc. 47
Chiesi
Farmaceutici SpA 48
Cilian
AG 49
Concert
Pharmaceuticals, Inc. 50
Corbus
pharmaceuticals, Inc. 51
CSA
Biotechnologies LLC 52
Cyclacel
Pharmaceuticals, Inc. 53
DiscoveryBiomed,
Inc. 54
Editas
Medicine, Inc. 55
Errant
Gene Therapeutics, LLC 56
Galapagos
NV 57
GlaxoSmithKline
Plc 58
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment